Albemarle Corporation is a specialty-chemicals company.
Albemarle Corporation (ALB) is expected to report earnings on Wednesday, November 4, 2026, after the close. Estimated release time 16:22 ET. Consensus EPS estimate is $2.55.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-05 | FY2026 Q2 | $3.20 | $3.72 | +16.2% | $1.74B |
| 2026-05-06 | FY2026 Q1 | $1.19 | $2.35 | +97.5% | $1.43B |
| 2025-11-05 | FY2025 Q3 | $-0.86 | $-1.72 | -99.7% | $1.31B |
| 2025-02-12 | FY2024 Q4 | $-0.60 | $-1.09 | -81.7% | $1.23B |
| 2024-05-01 | FY2024 Q1 | $0.25 | $0.26 | +2.9% | $1.36B |
| 2023-11-01 | FY2023 Q3 | $3.99 | $2.58 | -35.3% | $2.31B |
| 2023-08-02 | FY2023 Q2 | $4.27 | $5.54 | +29.7% | $2.37B |
| 2022-11-02 | FY2022 Q3 | $6.84 | $7.66 | +12.0% | $2.09B |
ALB has beaten consensus EPS in 5 of its last 8 reported quarters.
ALB reported Aug 5. The highlights: EPS of $3.72 — a big beat vs the $3.20 estimate (+16%); revenue of $1.74B — a beat vs the $1.61B consensus (+8%). Focus now shifts to lithium pricing and cost curve position.
ALB pays a quarterly dividend, currently yielding 1.20%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-09-11 | $0.41 | 2026-10-01 |
| 2026-06-12 | $0.405 | 2026-07-01 |
| 2026-03-13 | $0.405 | 2026-04-01 |
| 2025-12-12 | $0.405 | 2026-01-02 |
| 2025-09-12 | $0.405 | 2025-10-01 |
| 2025-06-13 | $0.405 | 2025-07-01 |